Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-10 @ 10:09 PM
Study NCT ID:
NCT05132504
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2021-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Sponsor:
Baylor College of Medicine
Organization: